Several existing drugs, including anti-viral medicines, are currently being trialled worldwide to treat Covid-19. – EPA pic, April 28, 2020.
THE arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill Covid-19 patients, according to a French clinical study. The treatment, which suppresses the body’s natural immune response, was found to reduce “significantly” the number of deaths or life support interventions compared with a control group of patients.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one week free access!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: